2008
DOI: 10.3998/ark.5550190.0010.316
|View full text |Cite
|
Sign up to set email alerts
|

Partial acylation of cytidine and its 2'-C-methyl analogue as a tool to functionalize the ribonucleosidic 2’,3’-cis-diol system

Abstract: Dedicated to Professor Harri Lönnberg on the occasion of his 60 th anniversary AbstractPrecisely controlled conditions of acylation and 2',3'-O-isomerization allowed to synthesize tripivaloyl derivatives of cytidine with free 2'-or 3'-hydroxyl group in a simple manner. Acylation of 2'-C-β-methylcytidine proceeded in a different way and resulted in the formation of tripivaloyl 2'-hydroxy nucleoside, or dipivaloyl 2',3'-dihydroxy compound. All these products may be applied as key intermediates in the regioselect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…Compound aa101 has been previously investigated for possible inhibition of the hepatitis C virus and of yellow fever virus in replicon assays and was found to be ineffective and also to have low toxicity. 36 While neither of the corresponding nucleosides was active in our NoV RdRp replicon assay, both were found to be chain terminators of NoV RdRp in the triphosphate form (Figure 6). A lack of either phosphorylation within the cells or cellular uptake is most likely responsible for the inactivity of the compounds in the replicon assay.…”
Section: Virtual Screening For Novel Nov Rdrp Nucleoside Inhibitorsmentioning
confidence: 89%
“…Compound aa101 has been previously investigated for possible inhibition of the hepatitis C virus and of yellow fever virus in replicon assays and was found to be ineffective and also to have low toxicity. 36 While neither of the corresponding nucleosides was active in our NoV RdRp replicon assay, both were found to be chain terminators of NoV RdRp in the triphosphate form (Figure 6). A lack of either phosphorylation within the cells or cellular uptake is most likely responsible for the inactivity of the compounds in the replicon assay.…”
Section: Virtual Screening For Novel Nov Rdrp Nucleoside Inhibitorsmentioning
confidence: 89%
“…Support from the Ministry of Education and Research of Estonia (grant IUT [19][20][21][22][23][24][25][26][27][28][29][30][31][32] and the EU Regional Development Fund Grant (3.2.0101.08-0017) are acknowledged. Notes and references…”
Section: Acknowledgementsmentioning
confidence: 99%
“…13 C NMR (100.6 MHz, CDCl 3 ) δ 178 23,. 178.08, 156.10 (broad), 140.21 (broad), 86.78, 81.74, 74.34, 64.05, 42.15, 39.02, 38.86, 38.79, 27.45, 27.33, 27.11 (signals from two carbons of the cytosine ring and quaternary carbon of the pivaloylamide carbonyl group were not detected due to strong line broadening and low intensity).…”
mentioning
confidence: 99%